HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A controlled clinical trial of iohexol and diatrizoate in aortofemoral angiography.

Abstract
Iohexol is a recently synthesized non-ionic low-osmolar contrast medium. It has been compared to the conventional ionic hyperosmolar contrast medium diatrizoate (Urografin 60%) in a randomized double-blind crossover study of aortofemoral angiographies of 50 consecutive patients. The intraarterial blood pressures, the pulse rate and ECG were recorded continuously and the reactions of pain and warmth were evaluated. Iohexol caused significantly less haemodynamic changes than Urografin and also the pain reactions were significantly reduced. The quality of the angiograms was equal.
AuthorsH Egsgaard, A Hørup, J Praestholm
JournalEuropean journal of radiology (Eur J Radiol) Vol. 3 Issue 1 Pg. 14-7 (Feb 1983) ISSN: 0720-048X [Print] Ireland
PMID6341063 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Contrast Media
  • Iodobenzoates
  • Triiodobenzoic Acids
  • Diatrizoate
  • Iohexol
Topics
  • Adult
  • Aged
  • Aortography
  • Chemical Phenomena
  • Chemistry
  • Clinical Trials as Topic
  • Contrast Media (adverse effects)
  • Diatrizoate (adverse effects)
  • Double-Blind Method
  • Female
  • Femoral Artery (diagnostic imaging)
  • Humans
  • Iodobenzoates (adverse effects)
  • Iohexol
  • Male
  • Middle Aged
  • Osmolar Concentration
  • Random Allocation
  • Triiodobenzoic Acids (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: